Das Spliceosom ist ein therapeutisches Target für Ras-induzierte Seneszenz und Tumoren mit Ras-Mutation
Year: 2023
Type: article
Institutions: Universitätsklinikum Tübingen, University of Tübingen, Instituto de Medicina Molecular João Lobo Antunes, MRC London Institute of Medical Sciences, Imperial College London, University College London, University of Dundee, University Hospital Heidelberg, Chirurgische Universitätsklinik Heidelberg, Weizmann Institute of Science, Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, Cancer Research UK Scotland Institute
Language: German
Topic: RNA Research and Splicing
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4387952182
